Literature DB >> 20332459

2'-Hydroxycinnamaldehyde shows antitumor activity against oral cancer in vitro and in vivo in a rat tumor model.

Soo-A Kim1, Young-Kwan Sung, Byoung-Mog Kwon, Jung-Hoon Yoon, Haeahm Lee, Sang-Gun Ahn, Su-Hyung Hong.   

Abstract

BACKGROUND: 2'-Hydroxycinnamaldehyde (HCA) exerts antitumor activity against several human cancer cell lines. However, its antitumor activity in oral cancer has not been demonstrated.
MATERIALS AND METHODS: The antitumor activity of HCA was assessed in oral cancer cell lines and in a rat oral tumor model.
RESULTS: Cell cycle analysis confirmed that HCA showed anti-proliferative activity via cell cycle arrest at the G(2)/M-phase and increased the number of cells in the sub-G(1) (apoptotic cells) phase in SCC-15 and HEp-2 oral cancer cells. Additionally, direct injection of HCA into an RK3E-ras-Fluc-induced tumor significantly inhibited growth of the tumor mass. Histological analysis showed that HCA decreased tumor cell proliferation and induced apoptosis in a rat tumor model.
CONCLUSION: Taken together, these observations suggest the potential value of HCA as a candidate for the treatment of oral cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332459

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer.

Authors:  Jong-Eun Kim; Joe Eun Son; Hyein Jeong; Dong Joon Kim; Sang Kwon Seo; Eunjung Lee; Tae Gyu Lim; Jong Rhan Kim; Hanyong Chen; Ann M Bode; Ki Won Lee; Zigang Dong
Journal:  Cancer Res       Date:  2015-05-06       Impact factor: 12.701

2.  2'-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice.

Authors:  Lihua Hao; Yuancheng Mao; Jin Park; Byoung-Mog Kwon; Eun Ju Bae; Byung-Hyun Park
Journal:  Exp Mol Med       Date:  2021-05-14       Impact factor: 8.718

3.  Cinnamaldehyde protects against oxidative stress and inhibits the TNF‑α‑induced inflammatory response in human umbilical vein endothelial cells.

Authors:  Nam-Yi Kim; Nguyet-Tran Trinh; Sang-Gun Ahn; Soo-A Kim
Journal:  Int J Mol Med       Date:  2020-04-16       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.